drugset / Trial / NCT07349459
Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
RandomizedParallel-groupDouble-blindPrevention
Summary
This study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Timeline
- Start
- 2026-04-30
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 10 mg | Oral |
| Subject | Vitamin D | Other / unclassified | 1000 iu | — |
| Comparator | Doxorubicin | Other / unclassified | — | — |